Prognostic value of pre-transplant 18-FDG PET/CT in Diffuse Large B Cell Lymphoma after R-DHAC salvage therapy
Conclusion: In patients with relapsing or refractory DLBCL treated with R-DHAC salvage therapy followed by ASCT, pre-transplant 18-FDG PET/CT SUVmax and whole-body TLG remains the strongest predictive factors of PFS and OS. While a Deauville score of 5 also carries a dismal prognosis, a Deauville score of 4 does not appear to preclude a successful ASCT.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Mesguich, C. Tags: Leukemia/Lymphoma/Myeloma Poster Session Source Type: research
More News: Chemotherapy | CT Scan | Leukemia | Lymphoma | Myeloma | Nuclear Medicine | PET Scan | Stem Cell Therapy | Stem Cells | Transplants